This post is sponsored by DIA.
New technology is creating novel ways to manage, source and analyze clinical data and could open the door to a new realm of possibility for pharmaceutical companies, CROs and others that rely on huge sets of data to create new health care products. Never before has there been the ability to manage data sets in a more nimble way and uncover connections that may have been missed amongst all the data compiled in long-term longitudinal studies and other research endeavors.
According to Informatica Corporation, “roughly 70 percent of any data project now involves simply managing data—integrating, transforming, and cleansing it—before any actual analysis can begin.“
When Investment Rhymes with Canada
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
These are time consuming tasks and contribute to the long timelines for clinical trial research. As companies face increasing pressure to accelerate trial times, new tools for faster and more meaningful data analysis will play a big role in how these accelerated timelines can be met. Cloud computing and new systems for analyzing large data sets allow scientists and researchers to spend less time sifting through data sets and more time discovering the critical insights that lead to innovation and the development of cutting edge therapies.
“How Pharmaceutical Companies and CROs Are Harnessing Big Data and Cloud Computing to Increase R&D Innovation, Efficiency, and Collaboration”, a forum presentation taking place at the DIA 2015 51st Annual Meeting, will examine how trial sponsors and CROs are leveraging advanced technologies to drive change, collaboration, and agility. Speakers will identify key challenges in information management and explain how new technologies and approaches can help with data mining and analysis for new indications and accelerate clinical development.
Jonathan Palmer, Senior Director, Product Strategy, Clinical Warehousing and Analytics at Oracle Health Sciences, will chair the session. He will be joined by Victor Lobanov, Executive Director Data Sciences at Covance Inc and Thomas Grundstrom, MA, Vice President, Integrated Informatics and Technology, ICON plc.
The potential for realizing what truly lies in the vast amounts of amassed research has never been greater. The more industry can harness, deconstruct, and analyze existing data, the greater insights, intelligence, and connections will be gained, leading to new innovation and products, improved relationships, and smoother, more efficient procedures. While issues of noise reduction in big data, privacy, security, and implementation struggles are important factors for consideration, in this fast-paced global marketplace, traditional pharmaceutical companies cannot afford to ignore the game-changing possibilities afforded by new technology.
A must-attend discussion for anyone involved with data preparation/analysis/mining, trial management, or IT implementation, the session will include commentary and real-world case studies. European and U.S. experts will discuss key challenges in information management and new technologies and its uses, including more efficient clinical trials and better audit defense.
The session, “How Pharmaceutical Companies and CROs Are Harnessing Big Data and Cloud Computing to Increase R&D Innovation, Efficiency, and Collaboration” will take place June 15, 8:30 – 10:00 am ET. The DIA 2015 51st Annual Meeting is truly a Meeting of the Minds bringing together key thought leaders and innovators from industry, academia, regulatory agencies, health, patient, and philanthropic organizations from around the globe across all disciplines involved in the discovery, development, and life cycle management of health care products. This year’s event offers more than 245 educational offerings over 20 tracks on today’s hottest topics, 450+ exhibiting companies, and more than 125 representatives from global regulatory agencies. The meeting provides participants with a valuable opportunity to network with professionals from around the world, share your views and knowledge, network and build new relationships.
Register for DIA 2015 51st Annual Meeting and join the conversation on Twitter @DrugInfoAssn using #DIA2015.
